← Eichor
Study identifier: NCT04629586 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The T1D Exchange Registry

Condition: Diabetes Mellitus, Type 1 · Diabetes · Type 1 Diabetes  ·  Sponsor: T1D Exchange, United States

PhaseN/A
Planned participants50000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes. To participate, you will be asked to: * Read and sign an online informed consent form * Take a survey describing specific demographic and type 1 diabetes management information * Update your information annually * Periodically opt in for additional research opportunities (if you choose), i.e. taking new surveys or uploading health device data

This description comes directly from the study's public registry record.

Talk to the study team

Kelsie LaFerrier  ·  (617) 892-9941  ·  klaferriere@t1dexchange.org

Julia Ravelson  ·  (617) 892-9941  ·  jravelson@t1dexchange.org

Always discuss trial participation with your own doctor first.

Locations (1)

T1D ExchangeBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04629586